Safety and Efficacy of Delayed-release Dimethyl Fumarate in Multiple Sclerosis Patients Treated in Routine Medical Practice: Interim Analysis of ESTEEM

被引：0
|
作者：
Everage, Nicholas J. [1 ]
Prada, Claudia [1 ]
Liu, Shifang [1 ]
Balashov, Konstantin [2 ]
Macdonell, Richard [3 ]
Windsheimer, Jorg [4 ]
Giles, Kathryn [5 ]
机构：
[1] Biogen, Cambridge, MA USA
[2] Rutgers State Univ, Robert Wood Johnson Med Sch, New Brunswick, NJ USA
[3] Univ Melbourne, Austin Hlth, Dept Neurol, Melbourne, Vic, Australia
[4] Praxis Neurol & Psychiat, Nurnberg, Germany
[5] Cambridge Mem Hosp, Cambridge, ON, Canada
来源：
NEUROLOGY | 2017年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P6.333
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Overall Safety and Efficacy Through 10 Years of Treatment with Delayed-Release Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis
    Gold, Ralf
    Giovannoni, Gavin
    Phillips, J. Theodore
    Bar-Or, Amit
    Fox, Robert J.
    Chen, Chongshu
    Parks, Becky
    Kapadia, Shivani
    NEUROLOGY, 2020, 94 (15)
  • [22] Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: Interim analysis of ENDORSE, a randomized extension study
    Gold, Ralf
    Arnold, Douglas L.
    Bar-Or, Amit
    Hutchinson, Michael
    Kappos, Ludwig
    Havrdova, Eva
    MacManus, David G.
    Yousry, Tarek A.
    Pozzilli, Carlo
    Selmaj, Krysztof
    Sweetser, Marianne T.
    Zhang, Ray
    Yang, Minhua
    Potts, James
    Novas, Mark
    Miller, David H.
    Kurukulasuriya, Nuwan C.
    Fox, Robert J.
    Phillips, Theodore J.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (02) : 253 - 265
  • [23] Lymphopenia in Patients with Multiple Sclerosis Treated with Delayed-Release Dimethyl Fumarate: Analysis of Two United States Electronic Health Record Databases
    Wenten, Made
    Soman, Teesta
    Lally, Cathy
    Juneja, Maneesh
    Eaton, Susan
    Prada, Claudia
    Dilley, Anne
    NEUROLOGY, 2016, 86
  • [24] Efficacy of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: integrated analysis of the phase 3 trials
    Viglietta, Vissia
    Miller, David
    Bar-Or, Amit
    Phillips, J. Theodore
    Arnold, Douglas L.
    Selmaj, Krzysztof
    Kita, Mariko
    Hutchinson, Michael
    Yang, Minhua
    Zhang, Ray
    Dawson, Katherine T.
    Sheikh, Sarah I.
    Fox, Robert J.
    Gold, Ralf
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2015, 2 (02): : 103 - 118
  • [25] Clinical efficacy of delayed-release dimethyl fumarate in Hispanic patients with relapsing-remitting multiple sclerosis: integrated analysis of define and confirm
    Hernandez, L.
    Fox, R. J.
    Gold, R.
    Phillips, J. T.
    Okwuokeny, M.
    Zhang, A.
    Rana, J.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E306 - E306
  • [26] Clinical efficacy of delayed-release dimethyl fumarate in Asian patients with relapsing-remitting multiple sclerosis: integrated analysis of define and confirm
    Hochman, S.
    Fox, R. J.
    Gold, R.
    Phillips, J. T.
    Okwuokeny, M.
    Zhang, A.
    Rana, J.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E306 - E307
  • [27] Efficacy and Safety of Delayed-release Dimethyl Fumarate for Relapsing-remitting Multiple Sclerosis in Prior Interferon Users: An Integrated Analysis of DEFINE and CONFIRM
    Fernandez, Oscar
    Giovannoni, Gavin
    Fox, Robert J.
    Gold, Ralf
    Phillips, J. Theodore
    Potts, James
    Okwuokenye, Macaulay
    Marantz, Jing L.
    CLINICAL THERAPEUTICS, 2017, 39 (08) : 1671 - 1679
  • [28] Time course of clinical and neuroradiological effects of delayed-release dimethyl fumarate in multiple sclerosis
    Kappos, L.
    Giovannoni, G.
    Gold, R.
    Phillips, J. T.
    Arnold, D. L.
    Hotermans, C.
    Zhang, A.
    Viglietta, V.
    Fox, R. J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 (04) : 664 - 671
  • [29] PATIENT CHARACTERISTICS AND TREATMENT ADHERENCE AMONG PATIENTS TREATED WITH DELAYED-RELEASE DIMETHYL FUMARATE FOR RELAPSING REMITTING MULTIPLE SCLEROSIS IN ISRAEL
    Desai, U.
    Huang, M.
    Kirson, N. Y.
    King, S.
    Hellstern, M.
    Schonfeld, S.
    Birnbaum, H. G.
    Lee, A.
    VALUE IN HEALTH, 2017, 20 (05) : A195 - A195
  • [30] A retrospective analysis of discontinuation rates and reasons for discontinuation in multiple sclerosis patients treated with delayed-release dimethyl fumarate (Biogen ONE Support Program)
    Vorobeychik, G.
    Potts, J.
    Smith, M.
    Vlaicu, M.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 301 - 302
12345